The Cystic Fibrosis Foundation practices venture philanthropy by making strategic investments in companies and technologies with the potential to treat or cure CF. We have a proven track record of accelerating the development of innovative therapies through financial investment, customized research materials, and clinical trial infrastructure.
Site Search
The Cystic Fibrosis Foundation offers a broad range of funding opportunities to support academic and industry investigators to pursue research on topics relevant to cystic fibrosis. Each application undergoes a rigorous scientific review process before funding is allocated.
This program is intended to facilitate research that will contribute to the development of new therapies or therapeutic strategies to treat cystic fibrosis with an emphasis on advancing CFTR gene repair and replacement approaches.
Through efficient study design, optimized clinical trial execution, and high-quality data, the Therapeutics Development Network (TDN) helps speed the delivery of new and better therapies to people with cystic fibrosis.
We offer awards for cystic fibrosis research and for professional development and training. Below is a list of current and upcoming funding opportunities.